Advertisement
Skip to Content

Kyowa Kirin Co Ltd KYKOF Stock Quote

| Rating as of

PINX: KYKOF

Last close prices updated as of Dec 27, 2022, 3:25 PM EST | USD
  • Last Close 22.284
  • Sector Healthcare
  • Industry Drug Manufacturers - General
  • Investment Style Large Growth
  • Day Range 22.28  –  22.28
  • Year Range 21.22  –  28.73
  • Market Cap 11.9770 Bil
  • Volume / Avg 788.0 /  911.3
  • Price / Sales 4.03
  • Price / Book 2.02
  • Forward Div Yield 1.64%
  • Trailing Div Yield 215.40%

Morningstar‘s Stock Analysis KYKOF

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics KYKOF

Company Profile KYKOF

Business Description

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Contact
1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube
Tokyo, 100-0004, JPN
Industry Drug Manufacturers - General
Employees 5,752

FAQs for Kyowa Kirin Co Ltd Stock

No. KYKOF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

KYKOF’s market cap is 11.98 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

KYKOF’s stock style is Large Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

KYKOF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare KYKOF’s historical performance against its industry peers and the overall market.